'Ventricular arrhythmias' diaporamas de présentation

Pharmacology Part 2

Pharmacology Part 2. IMEC INC. Quick Learning Technique. Treatment of Congestive Heart Failure. Cardiac Glycosides. Digitalis Mode of Action: Regulation of cytosolic calcium-inhibiting pump activity by reversibly binding with sodium-potassium ATPase

1.37k views • 119 slides

CLINICAL PHARMACOLOGY OF ANTIARRHYTHMIC MEDICATIONS

CLINICAL PHARMACOLOGY OF ANTIARRHYTHMIC MEDICATIONS. Vincent F. Mauro, PharmD, FCCP. Professor of Clinical Pharmacy and Adjunct Professor of Medicine The University of Toledo. GOALS. To have a better understanding of:

1.34k views • 90 slides

??? ???? ?????? ??????

??? ???? ?????? ??????. Antiarrythmic Drugs ???? ?? ???? ??????? ??? ????? ??????? ????? ???? ???? ???? ?? ??????? ?????? ??? ???????... ?? ??????? ??? ??? ????????? ?????? ??? ??????? ???? ?? ?? ???? ???? ??? ????? ????? ... ?? ????? ????? 426 ???? ????? ????????? ...

1.09k views • 65 slides

Circulatory and Respiratory System

957 views • 56 slides

Antiarrhythmic Drugs

Antiarrhythmic Drugs. Arrhythmia. Heart condition where disturbances in Pacemaker impulse formation Contraction impulse conduction Combination of the two Results in rate and/or timing of contraction of heart muscle that is insufficient to maintain normal cardiac output (CO)

986 views • 47 slides

THE ECG

826 views • 47 slides

Dynamic Image Reconstruction in Nuclear Medicine

704 views • 47 slides

Hypokalaemia

Hypokalaemia. By Dr Nihal Abosaif Consultant acute physician UHCW. Outline. Physiology of K+ transport Factors modifying transcellular K+ distribution Causes of Hypokalaemia Diseases associated with it Management of Hypokalaemia. Introduction : Potassium .

607 views • 43 slides

Down for the Count! The Evaluation of Syncope

Down for the Count! The Evaluation of Syncope. Wyatt W. Decker, M.D. Department of Emergency Medicine Mayo Clinic and Mayo Medical School. OUTLINE. Case Epidemiology Signs and symptoms What data help to risk-stratify patients with syncope? Who should be admitted after a syncopal event?.

501 views • 39 slides

Regulatory Perspectives on the Thorough QT/QTc Study

Regulatory Perspectives on the Thorough QT/QTc Study . 2005 FDA/Industry Workshop Washington DC September 16, 2005 Juan (Joanne) Zhang, Ph.D. CDER/FDA *Acknowledgement: Drs. Stella Machado & George Rochester. Disclaimer.

465 views • 37 slides

Risks of Psychotropics

Risks of Psychotropics. The Risks. Antidepressants Antipsychotics Adverse Effects Toxicity Significant Interactions. Tricyclic antidepressants. Mechanism of action Block reuptake of noradrenaline seratonin . Dose dependent increase in seratonin, noradrenaline and dopamine.

565 views • 32 slides

Antiarrhythmic Drugs

Antiarrhythmic Drugs. Drug List. Physiology Review. To function efficiently, heart needs to contract sequentially (atria, then ventricles) and in synchrony Relaxation must occur between contractions

667 views • 30 slides

THERAPEUTIC DRUG MONITORING (TDM)

THERAPEUTIC DRUG MONITORING (TDM) . Dr. Chaichan Sangdee Department of Pharmacology Faculty of Medicine Chiang Mai University. DO ALL DRUGS NEED TDM?. Drugs that do not need TDM:

1.74k views • 29 slides

ANTI-THROMBOTIC THERAPY IN ACUTE CORONARY SYNDROMES

491 views • 27 slides

Arrhytmia In Heart Failure

Arrhytmia In Heart Failure. Dr. Muhammad Fadil , SpJP Department of Cardiology and Vascular Medicine Medicine Faculty of Universitas Andalas / Dr. M. Djamil Hospital Padang. th. 4. SymCARD . 2014. Introduction.

438 views • 27 slides

Exercise Prescription for Cardiac Patients

Exercise Prescription for Cardiac Patients. Inpatient Programs. Benefits:. Risk Factor Modification Activity Counseling Patient and Family Education. Major Components of Cardiac Rehab:. Assessment of functional tolerance to activities of daily living

460 views • 22 slides

Nonpharmacologic Management and Health Care Maintenance in Patients with Chronic Heart Failure

426 views • 20 slides

ECG Rhythm Interpretation

437 views • 19 slides

Evaluation of Cardiac Safety by ECG Findings: Focus on QTc Duration

Evaluation of Cardiac Safety by ECG Findings: Focus on QTc Duration. Drugs Withdrawn for Potential Health Risk (Cardiac Arrest and Death). Drug Class Date Withdrawn Terfenadine Antihistamine Feb 1998 Sertindole Antipsychotic Dec 1998 Astemizole Antihistamine Jun 1999

311 views • 18 slides

OMEGA-3 FATTY ACIDS

bbc.co.uk. OMEGA-3 FATTY ACIDS. By: Brandi Barnhill,RN,BSN Melissa Cummins,RN,BSN Amanda Janisse,RN,BSN Janice Williams,RN,BSN. Polyunsaturated fatty acids (PUFA) 2 types of polyunsaturated fats based on the position of the first double bond site omega-3 fatty acids

536 views • 18 slides